Wird geladen...
Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
INTRODUCTION: Data from clinical studies on the long-term efficacy and safety of anti-tumor necrosis factor (TNF)-α therapy in patients with ankylosing spondylitis (AS) are scarce. This is the first report on continuous treatment with the TNFα fusion protein etanercept over seven years (y). METHODS:...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4060369/ https://ncbi.nlm.nih.gov/pubmed/23786760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4244 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|